FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV

FOSTER CITY, Calif.--(BUSINESS WIRE) April 26, 2024 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news